Abstract
An oversimplified and sensitive sensor based on MoWS2-modified screen-printed electrode (MoWS2/SPE) was designed in this study for detecting gliclazide (GLZ) and glibenclamide (GLB) that are two widespread employed drugs in treating noninsulin-dependent diabetes mellitus. MoWS2 exhibited very good electrocatalytic activities toward oxidation of GLZ and GLB in comparison with bare SPE in 0.1 M PBS, and the isolated capacities of oxidation peak assured concurrent determination of GLZ with widespread linear range between 0.06 and 500.0 μM. Determination limit of GLZ has been 18.0 nM (S/N = 3). MoWS2/SPE has good steadiness, repeatability, and reproducibility. This procedure has had a successful application in detecting GLZ and GLB in their biological and pharmaceutical specimens with acceptable recovery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
